More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

But the West Virginia abortion-pills case, GenBioPro v. Raynes, drew 10 friend-of-the-court briefs supporting the ...

Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story FDA reverses course on Juul The Food and Drug Administration is allowing Juul Labs to keep its electronic ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...

West Virginia enacted a law prohibiting abortion in most circumstances shortly following the Dobbs decision in 2022.

In this powerful statement, a Democratic lawmaker denounces the Trump administration’s escalating efforts to ban abortion nationwide—this time by targeting the widely used, FDA-approved drug ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Gov. Patrick Morrisey praised a decision made Tuesday by a federal appeals court in a case brought when he was attorney general challenging West Virginia’s near-total ban on abortion and limits on ...

A federal appeals court on Tuesday upheld a lower court’s decision to restrict abortion pill sales in West Virginia. A ...